Biomarin Pharmaceutical Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 08/07/2026 | 20.45 M | $1.17 B | 3.16% | 10.62% |
| DODGE & COX | 08/13/2026 | 14.84 M | $849.43 M | 1.94% | 7.71% |
| PRIMECAP MANAGEMENT CO/CA/ | 08/14/2026 | 14.19 M | $811.96 M | -0.03% | 7.37% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 8.74 M | $500.31 M | 1.16% | 4.54% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 8.65 M | $494.88 M | 4.22% | 4.49% |
| NORGES BANK | 08/12/2026 | 8.21 M | $469.66 M | 100.00% | 4.26% |
| STATE STREET CORP | 08/07/2026 | 7.80 M | $446.37 M | 6.93% | 4.05% |
| VIKING GLOBAL INVESTORS LP | 08/14/2026 | 7.62 M | $435.82 M | 7.85% | 3.96% |
| VESTAL POINT CAPITAL, LP | 08/14/2026 | 6.03 M | $344.75 M | 68.53% | 3.13% |
| AQR CAPITAL MANAGEMENT LLC | 08/14/2026 | 5.70 M | $322.54 M | -25.75% | 2.96% |
| FMR LLC | 08/13/2026 | 4.82 M | $275.97 M | 35.21% | 2.51% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 4.08 M | $233.22 M | 7.17% | 2.12% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 3.91 M | $223.89 M | 2.42% | 2.03% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 08/12/2026 | 3.50 M | $200.52 M | 0.37% | 1.82% |
| DEEP TRACK CAPITAL, LP | 08/14/2026 | 3.31 M | $189.25 M | 187.61% | 1.72% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 2.07 M | $118.55 M | -31.18% | 1.08% |
| ASSENAGON ASSET MANAGEMENT S.A. | 08/21/2026 | 1.76 M | $100.83 M | -8.26% | 0.92% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.62 M | $92.47 M | 1.78% | 0.84% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.62 M | $92.47 M | 100.00% | 0.84% |
| FIRST TRUST ADVISORS LP | 08/11/2026 | 1.61 M | $91.91 M | -3.96% | 0.83% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.56 M | $89.15 M | -1.78% | 0.81% |
| MORGAN STANLEY | 08/13/2026 | 1.50 M | $86.12 M | 13.87% | 0.78% |
| JONES HILL CAPITAL LP | 08/13/2026 | 1.43 M | $81.92 M | 12.87% | 0.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2026 | 1.33 M | $76.26 M | 56.52% | 0.69% |
| SWEDBANK AB | 07/15/2026 | 1.31 M | $75.23 M | 65.97% | 0.68% |
| UBS GROUP AG | 08/13/2026 | 1.29 M | $73.61 M | -14.05% | 0.67% |
| DNB ASSET MANAGEMENT AS | 08/11/2026 | 1.27 M | $72.57 M | 3.83% | 0.66% |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 08/14/2026 | 1.24 M | $70.75 M | 30.76% | 0.64% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.22 M | $70.03 M | 2.49% | 0.64% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 1.20 M | $68.78 M | 216.65% | 0.62% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 1.16 M | $66.26 M | -1.33% | 0.60% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 1.16 M | $66.11 M | 0.91% | 0.60% |
| CITADEL ADVISORS LLC | 08/14/2026 | 1.12 M | $64.22 M | -75.13% | 0.58% |
| BALYASNY ASSET MANAGEMENT L.P. | 08/14/2026 | 1.05 M | $60.34 M | -22.61% | 0.55% |
| ARGA INVESTMENT MANAGEMENT, LP | 07/31/2026 | 1.04 M | $59.47 M | 100.00% | 0.54% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 952.20 K | $54.48 M | 28.78% | 0.49% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 936.04 K | $53.56 M | 0.23% | 0.49% |
| MACKENZIE FINANCIAL CORP | 08/13/2026 | 931.86 K | $53.32 M | 111.09% | 0.48% |
| LSV ASSET MANAGEMENT | 08/06/2026 | 881.70 K | $50.45 M | -0.35% | 0.46% |
| HUDSON BAY CAPITAL MANAGEMENT LP | 08/14/2026 | 825.00 K | $47.21 M | -15.37% | 0.43% |
| RUSSELL INVESTMENTS GROUP, LTD. | 08/06/2026 | 783.15 K | $44.81 M | 29.18% | 0.41% |
| JUPITER TOPCO LLC | 08/14/2026 | 755.19 K | $43.21 M | 100.00% | 0.39% |
| UBS ASSET MANAGEMENT AMERICAS INC | 08/13/2026 | 735.72 K | $42.10 M | -13.53% | 0.38% |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | 07/17/2026 | 715.65 K | $40.95 M | 0.16% | 0.37% |
| LOOMIS SAYLES & CO L P | 08/14/2026 | 713.66 K | $40.84 M | -0.02% | 0.37% |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 08/13/2026 | 696.78 K | $39.87 M | 71.04% | 0.36% |
| JPMORGAN CHASE & CO | 08/12/2026 | 694.55 K | $40.57 M | 24.51% | 0.36% |
| NUVEEN, LLC | 08/11/2026 | 689.13 K | $39.43 M | -2.28% | 0.36% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 08/10/2026 | 687.03 K | $39.31 M | 0.15% | 0.36% |
| PALO ALTO INVESTORS LP | 08/19/2026 | 682.78 K | $39.07 M | -0.35% | 0.35% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Biomarin Pharmaceutical Inc. institutional Ownership - FAQ's
During the previous two years, 925 institutional investors and hedge funds held shares of Biomarin Pharmaceutical Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 20.45 M
DODGE & COX: 14.84 M
PRIMECAP MANAGEMENT CO/CA/: 14.19 M
VANGUARD CAPITAL MANAGEMENT LLC: 8.74 M
VANGUARD PORTFOLIO MANAGEMENT LLC: 8.65 M
NORGES BANK: 8.21 M
101.44% of Biomarin Pharmaceutical Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 267.82 M shares in the last 24 months. This purchase volume represents approximately $16.30 B in transactions.